申请人:ABBVIE INC.
公开号:US20140155382A1
公开(公告)日:2014-06-05
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
本发明描述了一种有效抑制丙型肝炎病毒(“HCV”)复制的化合物。本发明还涉及制备这些化合物的过程,包含这些化合物的组合物,以及使用这些化合物治疗HCV感染的方法。